首页> 外文期刊>Integrative cancer therapies >Orthomolecular oncology review: ascorbic acid and cancer 25 years later.
【24h】

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

机译:正分子肿瘤学评论:25年后抗坏血酸和癌症。

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of ascorbic acid on cancer has been a subject of great controversy. This is a follow-up review of the 1979 article by Cameron, Pauling, and Leibovitz published in Cancer Research. In this updated version, the authors address general aspects of ascorbic acid and cancer that have been presented before, while reviewing, analyzing, and updating new existing literature on the subject. In addition, they present and discuss their own mechanistic hypothesis on the effect of ascorbic acid on the cancer cell. The objective of this review is to provide an updated scientific basis for the use of ascorbic acid, especially intravenously as adjuvant treatment in pharmacological nutritional oncology.
机译:抗坏血酸对癌症的作用一直是一个备受争议的话题。这是卡梅隆(Cameron),鲍林(Pau​​ling)和莱博维茨(Leibovitz)于1979年发表在《癌症研究》上的后续评论。在此更新版本中,作者讨论了之前已经介绍过的抗坏血酸和癌症的一般方面,同时查看,分析和更新了有关该主题的新的现有文献。此外,他们提出并讨论了自己的关于抗坏血酸对癌细胞作用的机制假说。这篇综述的目的是为抗坏血酸的使用提供新的科学依据,尤其是静脉内作为抗药性营养肿瘤学的辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号